Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03064568 · ClinicalTrials.gov registry record · Phase 4
Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy
A Phase 4 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT03064568 is a Phase 4 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 18 participants.
The verdict
NCT03064568, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
Purpose is to identify if misoprostol in addition to local vasopressin decreases blood loss when compared to vasopressin alone, which is our current practice at this time. The study will be double-blinded with neither the patient nor the researcher knowing whether the placebo or the misoprostol was given. We will monitor patients for decrease in hemoglobin and hematocrit, need for transfusion, and operative time among other measures of perioperative morbidity to see if the addition of misoprostol makes a significant difference. We will also observe patients to see if there are any side effects of misoprostol that make its use undesirable.
Interventions
- DRUG Placebo
- DRUG Misoprostol 200Mcg Tab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-10-14 |
| Est. Completion | 2024-06-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03064568
The ClinicalTrials.gov registry entry for NCT03064568 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03064568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03064568 about?
NCT03064568 is a clinical study titled "Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy". Purpose is to identify if misoprostol in addition to local vasopressin decreases blood loss when compared to vasopressin alone, which is our current practice at this time. The study will be double-blinded with neither the patient nor the researcher knowing whether the placebo or the misoprostol was ...
What is the current status of trial NCT03064568?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2016-10-14. Estimated completion is 2024-06-18.
What interventions are being tested in trial NCT03064568?
The interventions under investigation include: Placebo (DRUG), Misoprostol 200Mcg Tab (DRUG).
Who is sponsoring clinical trial NCT03064568?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.